EP1012266A4 - Galectin 8, 9, 10 und 10sv. - Google Patents
Galectin 8, 9, 10 und 10sv.Info
- Publication number
- EP1012266A4 EP1012266A4 EP97912689A EP97912689A EP1012266A4 EP 1012266 A4 EP1012266 A4 EP 1012266A4 EP 97912689 A EP97912689 A EP 97912689A EP 97912689 A EP97912689 A EP 97912689A EP 1012266 A4 EP1012266 A4 EP 1012266A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- galectin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4726—Lectins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4724—Lectins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2809396P | 1996-10-09 | 1996-10-09 | |
WOPCT/US96/16565 | 1996-10-09 | ||
US28093P | 1996-10-09 | ||
US9616565 | 1996-10-09 | ||
PCT/US1997/018261 WO1998015624A1 (en) | 1996-10-09 | 1997-10-09 | Galectin 8, 9, 10 and 10sv |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1012266A1 EP1012266A1 (de) | 2000-06-28 |
EP1012266A4 true EP1012266A4 (de) | 2004-04-28 |
Family
ID=26703285
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP97912689A Withdrawn EP1012266A4 (de) | 1996-10-09 | 1997-10-09 | Galectin 8, 9, 10 und 10sv. |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1012266A4 (de) |
JP (1) | JP2001501831A (de) |
CA (1) | CA2268022A1 (de) |
WO (1) | WO1998015624A1 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999062556A1 (fr) * | 1998-06-03 | 1999-12-09 | Effector Cell Institute | Facteur chimiotactique pour les eosinophiles |
CN1302881A (zh) * | 1999-10-28 | 2001-07-11 | 上海博容基因开发有限公司 | 一种新的多肽——人β-半乳糖苷结合蛋白和编码这种多肽的多核苷酸 |
US6953658B2 (en) | 2000-03-09 | 2005-10-11 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancer |
CN1306271C (zh) * | 2000-11-01 | 2007-03-21 | 株式会社嘉尔药物 | 癌转移能力检测剂 |
EP1490403A2 (de) * | 2002-02-28 | 2004-12-29 | YEDA RESEARCH AND DEVELOPMENT Co. LTD. | Galectin-8 und funktionelle derivate als mittel zur bindung von cd44-glykoproteinen und anwendungsverfahren |
WO2003074673A2 (en) * | 2002-03-01 | 2003-09-12 | Exelixis, Inc. | Lgals as modifiers of the chk pathway and methods of use |
CA2505931A1 (en) * | 2002-11-14 | 2004-05-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
US20060009378A1 (en) | 2002-11-14 | 2006-01-12 | Itshak Golan | Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
CA2514108A1 (en) * | 2003-01-24 | 2004-08-05 | Galpharma Co., Ltd. | Drugs containing galectin 9 |
EP1619203A1 (de) * | 2003-04-28 | 2006-01-25 | Galpharma Co., Ltd. | Galectin 9-induzierender faktor |
DE10333406A1 (de) * | 2003-07-15 | 2005-02-10 | Protagen Ag | T-regulatorische-Zellen enthaltend Galectine zur Therapie und Diagnose von Erkrankungen |
EP1685159B1 (de) * | 2003-10-03 | 2012-08-01 | Brigham & Women's Hospital | Tim-3-polypeptide |
TW200539890A (en) | 2004-03-12 | 2005-12-16 | Brigham & Womens Hospital | Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
DK1736541T3 (da) * | 2004-03-29 | 2013-05-06 | Galpharma Co Ltd | Nyt modificeret galectin 9-protein og anvendelse heraf |
WO2005121340A1 (ja) * | 2004-06-14 | 2005-12-22 | Galpharma Co., Ltd. | 新規ガレクチン8改変体タンパク質及びその用途 |
CN1332030C (zh) * | 2005-04-28 | 2007-08-15 | 武汉大学 | 一种真菌半乳糖凝集素蛋白活性的多肽、其编码序列及制备方法和应用 |
JP2007131540A (ja) * | 2005-11-08 | 2007-05-31 | Galpharma Co Ltd | Cd44機能抑制因子による抗アレルギー薬、免疫抑制薬および抗腫瘍薬 |
CN102205111B (zh) * | 2011-05-19 | 2013-01-23 | 武汉大学 | 杨树菇半乳糖凝集素在制备抗hiv感染药物中的用途 |
WO2014171018A1 (ja) * | 2013-04-20 | 2014-10-23 | 株式会社ガルファーマ | 疾患の診断方法、疾患の治療または予防方法、疾患の診断用キット、疾患の治療または予防用医薬 |
JP5420791B1 (ja) * | 2013-08-23 | 2014-02-19 | 肇 福永 | サルモネラ菌及びシート状m細胞 |
MX2018013683A (es) * | 2016-05-10 | 2019-06-17 | Genentech Inc | Métodos para disminuir los enlaces de trisulfuro durante la producción recombinante de polipéptidos. |
JP7224583B2 (ja) * | 2018-01-29 | 2023-02-20 | 日本メナード化粧品株式会社 | ガレクチン-9産生促進剤 |
CN108409850A (zh) * | 2018-01-30 | 2018-08-17 | 河南师范大学 | 一种鱼源半乳糖凝集素CaGal重组蛋白的制备方法及其应用 |
CN113999287B (zh) * | 2021-12-02 | 2023-06-27 | 深圳湾实验室坪山生物医药研发转化中心 | 一种靶向半乳糖凝集素-10的多肽抑制剂及其制备方法和用途 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996021671A1 (en) * | 1995-01-11 | 1996-07-18 | The Trustees Of Columbia University In The City Of New York | Development of dna probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes |
WO1996039419A1 (en) * | 1995-06-06 | 1996-12-12 | Human Genome Sciences, Inc. | Colon specific genes and proteins |
WO1997003190A1 (fr) * | 1995-07-11 | 1997-01-30 | Sagami Chemical Research Center | PROTEINE HUMAINE SEMBLABLE A GALECTINE-4 ET ADNc CODANT CETTE PROTEINE |
-
1997
- 1997-10-09 CA CA002268022A patent/CA2268022A1/en not_active Abandoned
- 1997-10-09 EP EP97912689A patent/EP1012266A4/de not_active Withdrawn
- 1997-10-09 WO PCT/US1997/018261 patent/WO1998015624A1/en not_active Application Discontinuation
- 1997-10-09 JP JP10517750A patent/JP2001501831A/ja not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996021671A1 (en) * | 1995-01-11 | 1996-07-18 | The Trustees Of Columbia University In The City Of New York | Development of dna probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes |
WO1996039419A1 (en) * | 1995-06-06 | 1996-12-12 | Human Genome Sciences, Inc. | Colon specific genes and proteins |
WO1997003190A1 (fr) * | 1995-07-11 | 1997-01-30 | Sagami Chemical Research Center | PROTEINE HUMAINE SEMBLABLE A GALECTINE-4 ET ADNc CODANT CETTE PROTEINE |
Non-Patent Citations (4)
Title |
---|
HADARI ET AL: "Galectin-8: A new rat lectin, related to Galectin-4", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 270, no. 7, February 1995 (1995-02-01), pages 3447 - 3453, XP002272060 * |
HUFLEJT ET AL.: "Strikingly different localization of Galectin-3 and Galectin-4 in human colon adenocarcinoma T84 cells", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 272, no. 30, May 1997 (1997-05-01), pages 14294 - 14303, XP002272061 * |
See also references of WO9815624A1 * |
TÜRECI ET AL: "Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 272, no. 10, March 1997 (1997-03-01), pages 6416 - 6422, XP002272062 * |
Also Published As
Publication number | Publication date |
---|---|
JP2001501831A (ja) | 2001-02-13 |
EP1012266A1 (de) | 2000-06-28 |
CA2268022A1 (en) | 1998-04-16 |
WO1998015624A1 (en) | 1998-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1021185A4 (de) | Dihydropyrimidine und ihre verwendungen. | |
DE59704951D1 (en) | Plättchenförmiges titandioxidpigment | |
EP1012266A4 (de) | Galectin 8, 9, 10 und 10sv. | |
GB2333453B (en) | Colostrinin and uses thereof | |
EP0894807A4 (de) | GPIb-Lipidcomplex und dessen Anwendungen | |
DE59705192D1 (en) | Lcp-blends | |
DE59700372D1 (en) | Blockcopolymere | |
HUP9700446A3 (en) | Oilsuspension-concentrate and using thereof | |
DE59703905D1 (en) | Linearmotorgetriebene transportanlage | |
DE59704086D1 (en) | Twin-dualmode-filter | |
PL331523A1 (en) | Azolotrizines and azolopyrimidines | |
DE59702027D1 (en) | Bragg-modulator | |
DE59705556D1 (en) | Peripheralpumpe | |
HUP9900068A3 (en) | Fuse-switch and/or fuse-disconnector | |
AU131132S (en) | Handleset | |
SG44332A1 (en) | Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas | |
AU131198S (en) | Handleset | |
PL332044A1 (en) | 25-methylene and 24,25-epoxy marcphortines and paraherquamides | |
GB2352176B (en) | Colostrinin and uses thereof | |
DE59610178D1 (en) | Rotationspumpe | |
AU942P (en) | WOORIKEE 2000 Isopogon anemonifolius | |
AU131131S (en) | Handleset | |
AU131199S (en) | Handleset | |
GB9610406D0 (en) | Envirofoam 2000 | |
GB9604269D0 (en) | Poletech 2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19990507 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20040316 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7C 07K 14/47 A |
|
17Q | First examination report despatched |
Effective date: 20040721 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20070503 |